NO20090279L - Methods and Pharmaceutical Preparations to Assist in the Treatment of Chemotherapy-Induced Neuropathy - Google Patents

Methods and Pharmaceutical Preparations to Assist in the Treatment of Chemotherapy-Induced Neuropathy

Info

Publication number
NO20090279L
NO20090279L NO20090279A NO20090279A NO20090279L NO 20090279 L NO20090279 L NO 20090279L NO 20090279 A NO20090279 A NO 20090279A NO 20090279 A NO20090279 A NO 20090279A NO 20090279 L NO20090279 L NO 20090279L
Authority
NO
Norway
Prior art keywords
chemotherapy
treatment
methods
pharmaceutical preparations
assist
Prior art date
Application number
NO20090279A
Other languages
Norwegian (no)
Inventor
Luigi Lenaz
Guru Reddy
Dorla Mirejovsky
Original Assignee
Spectrum Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spectrum Pharmaceuticals Inc filed Critical Spectrum Pharmaceuticals Inc
Publication of NO20090279L publication Critical patent/NO20090279L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Fremgangsmåter og farmasøytiske fremstilling for å anvende en leteprinimsuspensjon for å bidra til behandlingen av kjemoterapiindusert nevropati.Methods and pharmaceutical preparations for using an exploratory primate suspension to aid in the treatment of chemotherapy-induced neuropathy.

NO20090279A 2006-08-01 2009-01-19 Methods and Pharmaceutical Preparations to Assist in the Treatment of Chemotherapy-Induced Neuropathy NO20090279L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82108206P 2006-08-01 2006-08-01
PCT/US2007/075008 WO2008017000A2 (en) 2006-08-01 2007-08-01 Methods and pharmaceutical preparations for contributing to the treatment of chemotherapy-induced neuropathy

Publications (1)

Publication Number Publication Date
NO20090279L true NO20090279L (en) 2009-02-26

Family

ID=38744846

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090279A NO20090279L (en) 2006-08-01 2009-01-19 Methods and Pharmaceutical Preparations to Assist in the Treatment of Chemotherapy-Induced Neuropathy

Country Status (12)

Country Link
EP (1) EP2046335A2 (en)
JP (1) JP2009545619A (en)
KR (1) KR20090047501A (en)
CN (1) CN101657199A (en)
BR (1) BRPI0715504A2 (en)
CA (1) CA2659477A1 (en)
IL (1) IL196824A0 (en)
MX (1) MX2009001116A (en)
NO (1) NO20090279L (en)
RU (1) RU2009107123A (en)
WO (1) WO2008017000A2 (en)
ZA (1) ZA200900728B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE499103T1 (en) * 2000-07-07 2011-03-15 Spectrum Pharmaceuticals Inc METHOD FOR TREATING DRUG-INDUCED PERIPHERAL NEUROPATHY AND RELATED MEDIA

Also Published As

Publication number Publication date
WO2008017000A3 (en) 2008-03-20
JP2009545619A (en) 2009-12-24
EP2046335A2 (en) 2009-04-15
MX2009001116A (en) 2009-02-10
WO2008017000A2 (en) 2008-02-07
WO2008017000A8 (en) 2009-04-30
IL196824A0 (en) 2009-11-18
BRPI0715504A2 (en) 2014-05-06
RU2009107123A (en) 2010-09-10
ZA200900728B (en) 2010-03-31
CA2659477A1 (en) 2008-02-07
KR20090047501A (en) 2009-05-12
CN101657199A (en) 2010-02-24

Similar Documents

Publication Publication Date Title
NO20170633A1 (en) Compounds of indolamine-2,3-dioxygenase for use in the treatment of cancer in combination with an anti-PD-1 antibody.
CY1113074T1 (en) ANTIBODIES AND IMMUNITIES AND USES OF THESE
LTPA2017009I1 (en) Bruton tyrosine kinase inhibitors
NO20090305L (en) Cyclosporine formulations
CY1114926T1 (en) ANTIBODIES AND IMMUNITIES AND USES OF THESE
MY148635A (en) Anti-tat226 antibodies and immunoconjugates
MX2012007684A (en) Ligand-directed covalent modification of protein.
PH12016501995A1 (en) Tubulysin derivatives
MX2009006327A (en) Heterocycle compounds and methods of use thereof.
CY1112383T1 (en) Inhibitors of Protein Activation of 5-Lipoxygenase (FLAP)
EA200801164A3 (en) PROTEIN INHIBITORS ACTIVATING 5-LIPOXYENASE (FLAP)
EA200900040A1 (en) ANTIBODY MOLECULES THAT ASSOCIATE WITH HUMAN IL-17
EA200870185A1 (en) COMBINATION OF ANG2 AND VEGF INHIBITORS
EP2061456A4 (en) Compositions and methods for inhibiting cytochrome p450
DK2013166T3 (en) N-carbamoylmethyl-4 (R) -phenyl-2-pyrrolidone, process for its preparation and pharmaceutical use
EA200701072A1 (en) PREPARATIONS FOR BENZHOIAZOLE AND THEIR USE
DE602008003199D1 (en) GLUCOSEISOMERASE FOR THE TREATMENT OF FRUCTOSE INCOMPATIBILITY
CL2007001910A1 (en) Compounds derived from penem; pharmaceutical composition; and use in the treatment of a bacterial infection.
IL183547A0 (en) Detection and quantitation of cyclodextrins
NO20073772L (en) Preparations comprising an epothilone and preparation method
NO20090279L (en) Methods and Pharmaceutical Preparations to Assist in the Treatment of Chemotherapy-Induced Neuropathy
ATE481392T1 (en) BENZIMIDAZOLE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES
EA200870597A1 (en) PHARMACEUTICAL APPLICATION OF PROTEIN MOLECULES IMMUNOLOGICALLY ASSOCIATED WITH DIFFTERIUM TOXIN
AU2016204324A1 (en) Antibody formulation
UA37057U (en) Method for treating papillomavirus infection

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application